Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 103
interventional 78
Observational 23
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 54
Drug|placebo 14
Other 4
Dietary Supplement|placebo 2
Device 1
Dietary Supplement 1
Drug|Other 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 19
NA 9
Turkey 6
China 3
Germany 3
Korea, Republic of 3
Brazil 2
Canada 2
Denmark 2
Egypt 2
Iran, Islamic Republic of 2
Italy 2
United Kingdom 2
Argentina 1
Argentina|Australia|Canada|Germany|Japan|Mexico|Thailand|United Kingdom 1
Australia 1
Austria 1
Belgium 1
Canada|Malaysia|Netherlands 1
China|Japan 1
France 1
Hong Kong 1
Mexico 1
Norway 1
Poland 1
Slovakia|Spain|Czech Republic|Estonia|Germany|Netherlands|Poland 1
Slovenia 1
Spain 1
United States|Argentina|Australia|Chile|Mexico|Peru|Turkey 1
United States|Argentina|Brazil|Bulgaria|Canada|Denmark|France|Hungary|Italy|Mexico|Romania 1
United States|Brazil|Bulgaria|Canada|Denmark|Germany|Hungary|Italy|Mexico|Romania|South Africa 1
United States|Canada 1
United States|Canada|Chile|Mexico|Turkey 1
United States|Canada|Denmark|France|Germany|Greece|Italy|Netherlands|Romania|Russian Federation|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 60
2 4
4 1
7 1
10 1
12 2
15 1
16 2
26 1
27 1
28 1
47 1
107 1
116 1

Phase

Phase Study_Count
Phase 4 26
N/A 20
Phase 2 15
Phase 3 13
Phase 1 2
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 11
2 36
3 10
4 1
5 3
6 1
NA 16

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.00000 21.00 17.0000 60.0 20.0000 15.0000
1st Qu. 15.00000 21.25 32.0000 62.5 71.2500 26.2500
Median 30.00000 21.50 40.0000 65.0 144.0000 70.0000
Mean 32.17647 21.50 113.5333 65.0 187.3333 116.6154
3rd Qu. 44.00000 21.75 111.0000 67.5 277.5000 105.7500
Max. 70.00000 22.00 496.0000 70.0 577.0000 509.0000

Trial Group Type

group_type Group_Count
Experimental 56
Active Comparator 45
Placebo Comparator 20
NA 16
Other 13
No Intervention 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 45
Crossover Assignment 18
Single Group Assignment 15

Primary Purpose

primary_purpose Study_Count
Treatment 66
Prevention 5
Other 2
Basic Science 1
Diagnostic 1
Screening 1
Supportive Care 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 15
France 2
Canada 1
Denmark 1
Ghana 1
NA 1
Sri Lanka 1
United States|Slovenia 1

Sites per Study

Site_count Study_Count
1 17
2 2
3 1
6 1
20 1
24 1

Enrollment Metrics

Measure Observational
Min 12.0
1st Qu 45.0
Median 200.0
Mean 435268.9
3rd Qu 372.0
Max 9999999.0

Observation Model

observational_model Study_Count
Cohort 9
NA 4
Other 3
Case-Control 2
Family-Based 2
Case-Only 1
Case Control 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 19
Retrospective 2
Cross-Sectional 1
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
China 1
Portugal|Argentina|Austria|Belarus|Belgium|Bosnia and Herzegovina|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Hungary|Iceland|Ireland|Israel|Italy|Latvia|Lithuania|Luxembourg|Netherlands|Norway|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1

Sites per Study

Site_count Study_Count
1 1
110 1

Enrollment Metrics

Measure Registries
Min 1200
1st Qu 6650
Median 12100
Mean 12100
3rd Qu 17550
Max 23000

Registry Model

observational_model Study_Count
Case-Only 1
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
24 Months 1
30 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03195023 Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) https://ClinicalTrials.gov/show/NCT03195023 Recruiting Hospital General Universitario Gregorio Marañon 2019-12-31
NCT03190694 Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria https://ClinicalTrials.gov/show/NCT03190694 Active, not recruiting University Medical Center Groningen 2019-11-01
NCT02633046 Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria https://ClinicalTrials.gov/show/NCT02633046 Active, not recruiting Mallinckrodt 2020-08-28
NCT02599532 Pharmacokinetics of Apixaban in Nephrotic Syndrome https://ClinicalTrials.gov/show/NCT02599532 Completed University of North Carolina, Chapel Hill 2019-06-28
NCT02373241 Preventing Sickle Cell Kidney Disease https://ClinicalTrials.gov/show/NCT02373241 Active, not recruiting University of Alabama at Birmingham 2021-04-30
NCT02532790 The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children https://ClinicalTrials.gov/show/NCT02532790 Recruiting Nanjing Children’s Hospital 2020-07-31
NCT02522650 A Crossover Pilot Study of the Effect of Amiloride on Proteinuria https://ClinicalTrials.gov/show/NCT02522650 Recruiting Georgetown University 2021-10-31
NCT02327403 Belatacept Conversion in Proteinuric Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT02327403 Active, not recruiting Brigham and Women’s Hospital 2020-09-30
NCT02282930 Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression https://ClinicalTrials.gov/show/NCT02282930 Completed Mayo Clinic 2018-06-30
NCT02232763 Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria https://ClinicalTrials.gov/show/NCT02232763 Completed Seoul National University Hospital 2016-07-31
NCT02090608 Paricalcitol in Fabry Disease https://ClinicalTrials.gov/show/NCT02090608 Completed Federico II University 2013-12-31
NCT02020785 Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23 https://ClinicalTrials.gov/show/NCT02020785 Completed Geisinger Clinic 2015-09-30
NCT02000440 A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) https://ClinicalTrials.gov/show/NCT02000440 Completed GlaxoSmithKline 2016-02-29
NCT01967355 Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis https://ClinicalTrials.gov/show/NCT01967355 Completed University Hospital Freiburg 2014-05-08
NCT01831193 Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT01831193 Completed Instituto Nacional de Cardiologia Ignacio Chavez 2014-04-30
NCT01828138 Hypertension and Urine Protease Activity in Preeclampsia https://ClinicalTrials.gov/show/NCT01828138 Completed Odense University Hospital 2015-10-31
NCT01827202 RAS Quantification in Patients With Aliskiren or Candesartan https://ClinicalTrials.gov/show/NCT01827202 Completed Medical University of Vienna 2016-02-29
NCT01738945 Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose https://ClinicalTrials.gov/show/NCT01738945 Completed Gulhane School of Medicine 2009-05-31
NCT01703234 FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients https://ClinicalTrials.gov/show/NCT01703234 Completed Gulhane School of Medicine 2009-03-31
NCT01694160 Oral Paricalcitol in Renal Transplant Recipients for Reducing Albuminuria https://ClinicalTrials.gov/show/NCT01694160 Completed Oslo University Hospital 2015-01-31
NCT01601236 Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients https://ClinicalTrials.gov/show/NCT01601236 Completed Mallinckrodt 2016-01-31
NCT01588795 Renal Denervation in Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT01588795 Completed Assistance Publique - Hôpitaux de Paris 2016-01-31
NCT00810732 Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects https://ClinicalTrials.gov/show/NCT00810732 Completed Pfizer 2009-03-31
NCT01541267 The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria https://ClinicalTrials.gov/show/NCT01541267 Completed Medical University of Gdansk 2011-05-31
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT01436747 Completed University Medical Centre Ljubljana 2014-10-31
NCT01386554 Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients https://ClinicalTrials.gov/show/NCT01386554 Completed Mallinckrodt 2016-11-21
NCT04171778 Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria https://ClinicalTrials.gov/show/NCT04171778 Recruiting University of Rochester 2021-12-31
NCT04169776 Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome https://ClinicalTrials.gov/show/NCT04169776 Recruiting Northwell Health 2020-12-30
NCT04058951 Plant Versus Animal Dietary Protein and the Effect on Proteinuria https://ClinicalTrials.gov/show/NCT04058951 Recruiting University of Copenhagen 2020-03-31
NCT04051957 Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury https://ClinicalTrials.gov/show/NCT04051957 Recruiting The University of Texas Health Science Center, Houston 2020-03-31
NCT03983551 Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas https://ClinicalTrials.gov/show/NCT03983551 Completed Changhua Christian Hospital 2018-02-10
NCT03573102 Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients https://ClinicalTrials.gov/show/NCT03573102 Recruiting Ain Shams University 2020-06-30
NCT03550859 HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria https://ClinicalTrials.gov/show/NCT03550859 Recruiting Yuhan Corporation 2020-08-31
NCT01225445 Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT01225445 Completed Chinese University of Hong Kong 2010-06-30
NCT01219413 Influence of Aliskiren on Proteinuria https://ClinicalTrials.gov/show/NCT01219413 Completed Medical University of Gdansk 2010-07-31
NCT01044771 Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria https://ClinicalTrials.gov/show/NCT01044771 Completed Metropolis Medical 2010-12-31
NCT01029002 The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT01029002 Completed Albert Einstein College of Medicine 2014-06-30
NCT01028287 Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) https://ClinicalTrials.gov/show/NCT01028287 Completed Southeast Renal Research Institute 2010-12-31
NCT01015937 Effect of Turmeric on Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT01015937 Completed Shaheed Faghihi Hospital 2009-06-30
NCT00983034 The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy https://ClinicalTrials.gov/show/NCT00983034 Completed Istanbul University 2008-12-31
NCT00977977 Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy https://ClinicalTrials.gov/show/NCT00977977 Recruiting National Institutes of Health Clinical Center (CC) 2021-01-01
NCT00935389 Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria https://ClinicalTrials.gov/show/NCT00935389 Completed Nanjing University School of Medicine 2011-04-30
NCT00915200 N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT00915200 Completed The University of Texas Health Science Center at San Antonio 2016-04-30
NCT00893425 Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria https://ClinicalTrials.gov/show/NCT00893425 Completed Gulhane School of Medicine 2009-03-31
NCT01382303 Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT01382303 Completed Ajou University School of Medicine 2013-12-20
NCT01265563 N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT01265563 Completed VA Office of Research and Development 2015-02-28
NCT00921570 The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension https://ClinicalTrials.gov/show/NCT00921570 Completed Gulhane School of Medicine 2009-05-31
NCT01637259 MARCH Renal Substudy https://ClinicalTrials.gov/show/NCT01637259 Completed Kirby Institute 2015-12-31
NCT00801463 Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis https://ClinicalTrials.gov/show/NCT00801463 Completed Nanjing University School of Medicine 2011-01-31
NCT03155919 Taurine Supplementation and Triathletes https://ClinicalTrials.gov/show/NCT03155919 Completed University of Sao Paulo 2014-06-30
NCT00768638 Study of Atorvastatin Dose Dependent Reduction of Proteinuria https://ClinicalTrials.gov/show/NCT00768638 Completed Laval University 2014-05-31
NCT00722215 Endothelin Receptor Antagonism in Proteinuric Nephropathy https://ClinicalTrials.gov/show/NCT00722215 Completed University of Edinburgh 2007-11-30
NCT00674596 The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria https://ClinicalTrials.gov/show/NCT00674596 Completed Gulhane School of Medicine 2008-03-31
NCT00663949 Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT00663949 Completed Shiraz University of Medical Sciences 2007-12-31
NCT00572663 Optimalization of Nephroprotection Using N-Acetylcysteine https://ClinicalTrials.gov/show/NCT00572663 Completed Medical University of Gdansk NA
NCT00568178 An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) https://ClinicalTrials.gov/show/NCT00568178 Completed Merck Sharp & Dohme Corp. 2008-09-01
NCT00550095 To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00550095 Completed Novartis 2009-11-30
NCT00528385 Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System https://ClinicalTrials.gov/show/NCT00528385 Completed Medical University of Gdansk NA
NCT00507494 Influence of Pioglitazone for Renal Transplant Function in Diabetics https://ClinicalTrials.gov/show/NCT00507494 Completed Technische Universität Dresden 2009-09-30
NCT00498537 Spironolactone for Reducing Proteinuria in Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT00498537 Completed VA Office of Research and Development 2005-12-31
NCT00493727 Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria https://ClinicalTrials.gov/show/NCT00493727 Completed VA Office of Research and Development 2007-12-31
NCT00464503 Statins and the Urinary Proteome https://ClinicalTrials.gov/show/NCT00464503 Completed Universiteit Antwerpen 2007-10-31
NCT00419835 Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00419835 Completed University of Sao Paulo 2007-09-30
NCT00367562 Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy https://ClinicalTrials.gov/show/NCT00367562 Completed Hospital Britanico NA
NCT00362960 Olmesartan Medoxomil and Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT00362960 Completed Daiichi Sankyo, Inc. NA
NCT00324675 Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy https://ClinicalTrials.gov/show/NCT00324675 Completed Technische Universität Dresden 2008-12-31
NCT00296400 Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease https://ClinicalTrials.gov/show/NCT00296400 Completed AstraZeneca 2009-06-30
NCT00296374 Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease https://ClinicalTrials.gov/show/NCT00296374 Completed AstraZeneca 2009-03-31
NCT00242346 High Doses of Candesartan Cilexetil on the Reduction of Proteinuria https://ClinicalTrials.gov/show/NCT00242346 Completed AstraZeneca NA
NCT00241085 Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT00241085 Completed Novartis 2005-08-31
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) https://ClinicalTrials.gov/show/NCT00234871 Completed Abbott 2005-03-31
NCT00199927 Statins in Proteinuric Nephropathies https://ClinicalTrials.gov/show/NCT00199927 Completed Mario Negri Institute for Pharmacological Research 2007-12-31
NCT00141453 ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial https://ClinicalTrials.gov/show/NCT00141453 Completed Daiichi Sankyo, Inc. 2008-08-31
NCT00106561 Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney https://ClinicalTrials.gov/show/NCT00106561 Completed Melbourne Health NA
NCT00097955 Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria https://ClinicalTrials.gov/show/NCT00097955 Completed Novartis 2007-04-30
NCT00067990 Angiotensin II Blockade for Chronic Allograft Nephropathy https://ClinicalTrials.gov/show/NCT00067990 Completed University of Minnesota 2011-06-30
NCT00572312 Optimalization of Nephroprotection Using Atorvastatin (Sortis) https://ClinicalTrials.gov/show/NCT00572312 Completed Medical University of Gdansk NA
NCT00001959 Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) https://ClinicalTrials.gov/show/NCT00001959 Completed National Institutes of Health Clinical Center (CC) 2008-10-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02818192 Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) https://ClinicalTrials.gov/show/NCT02818192 Recruiting University of Manitoba 2020-09-30
NCT02798042 Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery? https://ClinicalTrials.gov/show/NCT02798042 Recruiting NYU Langone Health 2020-09-30
NCT02780414 Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers https://ClinicalTrials.gov/show/NCT02780414 Recruiting Progenity, Inc. 2020-05-31
NCT00001978 Determination of Kidney Function https://ClinicalTrials.gov/show/NCT00001978 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02226055 An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka https://ClinicalTrials.gov/show/NCT02226055 Completed University of Edinburgh 2017-05-01
NCT02194582 Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure https://ClinicalTrials.gov/show/NCT02194582 Active, not recruiting Beth Israel Deaconess Medical Center 2035-01-31
NCT01572857 Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma https://ClinicalTrials.gov/show/NCT01572857 Completed Rennes University Hospital 2018-01-31
NCT01410994 Bariatric Surgery and the Kidney https://ClinicalTrials.gov/show/NCT01410994 Completed Indiana University 2014-04-30
NCT04059211 Sensitivity and Specificity of Urinary Dipstick in Emergency Departments https://ClinicalTrials.gov/show/NCT04059211 Recruiting Sonderborg Hospital 2019-09-01
NCT03842917 SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF) https://ClinicalTrials.gov/show/NCT03842917 Recruiting University Hospital, Tours 2021-07-31
NCT03767803 Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women https://ClinicalTrials.gov/show/NCT03767803 Active, not recruiting Progenity, Inc. 2020-12-31
NCT03644771 Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte Function https://ClinicalTrials.gov/show/NCT03644771 Recruiting Greater Boston Medical Associates 2021-12-31
NCT03510286 Validation of a PrCr Dipstick Diagnostic Test in Ghana https://ClinicalTrials.gov/show/NCT03510286 Active, not recruiting PATH 2020-09-30
NCT01248169 Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy https://ClinicalTrials.gov/show/NCT01248169 Completed University of Mississippi Medical Center 2013-07-31
NCT01156428 Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease https://ClinicalTrials.gov/show/NCT01156428 Completed The Rogosin Institute 2016-11-30
NCT01094327 Proteinuria in Pre and Post Transplant https://ClinicalTrials.gov/show/NCT01094327 Recruiting University of Miami 2021-12-31
NCT00849394 Evaluation of Protein in the Urine in Patients Receiving Bevacizumab https://ClinicalTrials.gov/show/NCT00849394 Completed North Texas Veterans Healthcare System 2012-06-30
NCT00654771 Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation https://ClinicalTrials.gov/show/NCT00654771 Completed University of Pittsburgh 2006-05-31
NCT00524992 Evaluation of Albuminuria HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00524992 Completed National Institutes of Health Clinical Center (CC) NA
NCT00446862 The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study https://ClinicalTrials.gov/show/NCT00446862 Completed University of Alabama at Birmingham 2012-06-30
NCT00395005 Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients https://ClinicalTrials.gov/show/NCT00395005 Completed National Taiwan University Hospital NA
NCT00343577 Antiproteinuric Agents and Fabry Disease https://ClinicalTrials.gov/show/NCT00343577 Completed University of Alabama at Birmingham NA
NCT00153621 Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00153621 Completed Children’s National Research Institute NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03015974 Registry of IgA Nephropathy in Chinese Children https://ClinicalTrials.gov/show/NCT03015974 Recruiting Peking University First Hospital 2020-06-30
NCT02699736 EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV https://ClinicalTrials.gov/show/NCT02699736 Enrolling by invitation Rigshospitalet, Denmark 2030-12-31